Evogene | EVGN - Cash And Equivalent



Evogene reported $8.33M in Cash and Equivalent for its fiscal quarter ending in June of 2025.


Cash And Equivalent Change Date
CVR Partners USD 114.4M 23.54M Jun/2025
Evogene USD 8.33M 2.99M Jun/2025
Hawkins USD 14.5M 9.4M Jun/2025
Innospec USD 266.6M 33.2M Jun/2025
Koppers USD 38.4M 5.5M Jun/2025
Kronos Worldwide USD 18.9M 87.8M Jun/2025
Materion USD 12.59M 3.04M Jun/2025
Minerals Technologies USD 313.8M 7.2M Jun/2025
Rayonier Advanced Materials USD 70.68M 54.32M Jun/2025
Sensient Technologies USD 56.69M 24.11M Jun/2025
Stepan USD 107.49M 7.83M Mar/2025
Tronox USD 132M 6M Jun/2025
Valhi USD 188.5M 159.8M Jun/2025
WD-40 USD 53M 1.92M Feb/2025